The slip
PARKINSON RECEIPTno. 12938
28 Oct 2026, 10:44 UTColigodendrocytes, braak
predictionDDO in oligodendrocytes tracks Braak Lewy-body stage
registered5f63e513da5321fc
discovery-0.11 p=0.784 n=9
replication+0.13 p=0.739 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.11, p 0.784)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT68b6b25cf5d03907921ce14f…
follows 7a46366fa567…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12938: DDO in oligodendrocytes, braak
- power
- full sample -0.02 (p 0.949, n 18), 95% CI -0.48 to +0.45. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.05 (p 0.834, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.07 (p 0.794, n 18). could be the mix.
- skeptic
- leave-one-out range -0.16 to +0.13, sign flips 7; without severely affected donors -0.02 (p 0.949, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DDO in oligodendrocytes.
case closed: nothing better to follow up.